#6 - Blood Tests That Detect 95% Of All Known Cancer

LATEST BREAKTHROUGH: Volition’s Capture-Seq™ Blood Test Detects 95% of Early-Stage Cancers

March 25, 2026 — VolitionRx just announced proof-of-concept results from their Capture-Seq™ liquid biopsy technology that achieves over 95% sensitivity for Stage I & II cancers with 95% specificity in a blinded validation study of 81 patients (59 cancer, 22 controls).

The Game-Changer Results

Cancer Stage	Detection Rate
Stage I	94% (17/18)
Stage II	96% (26/27)
Stage III	100% (2/2)
Stage IV	91% (10/11)
Overall	93% sensitivity

How it works: Proprietary method delivers >99% pure circulating tumor DNA (ctDNA) from blood by physically enriching samples then bioinformatically removing non-tumor DNA. First liquid biopsy achieving virtually pure cancer DNA sequencing.

Why This Matters for Cancer Warriors

Stage I/II detection = 5-year survival jumps from 25-40% to 80-95%. Current screening (mammogram, colonoscopy) misses 20-50% early cancers. Capture-Seq™ targets colorectal/lung now, plans multi-cancer expansion.

LuxSpei Context: While awaiting tests like this, music + attitude fuel immune surveillance during “watchful waiting.” Volition proves early detection works—your immune support maximizes those extra years.

Current Status

Proof-of-concept validated (March 2026)
Multiple patents filed on nucleoprotein tech
$36B market (MCED + MRD monitoring)
Larger trials next for FDA path

Comparison to Competitors

Test	Early Stage Sensitivity	Status
Volition Capture-Seq	95% Stage I/II	POC validated
Grail Galleri	16-50% early stage	Failed major trial
Guardant Shield	CRC-focused	FDA-approved

Bottom line: First blood test hitting 95% early detection. If validated in Phase III trials, changes cancer from death sentence to manageable chronic disease.

For LuxSpei readers: Keep immune support strong. Tests like this mean more survivors need your music, pendants, and hope.

References: VolitionRx press release (3/25/26), Clinical Lab Products

The Cancer Collectives is a LuxSpei.org product

Editors Corner:

In this Breast Cancer Awareness month, know this:
your fear is real, your pain
is felt, and your hope is fierce. Strength isn’t just in the battle – it’s in each
breath you take when the weight feels unbearable.
You are never alone; even
in the silence, the power of your hope and the light of your purpose
shine brighter than anything cancer brings on.

Believe it.

Remember, your emotional well-being is just as vital as any medicine.

Disclaimer

The information presented in this newsletter is intended for general informational purposes only. While we strive to ensure that all content is accurate and up to date, The Cancer Collectives makes no guarantees regarding the completeness, reliability, or accuracy of any information provided.

Nothing contained in this newsletter should be construed as medical advice, diagnosis, or treatment. All content, including articles, features, and responses from contributors or medical professionals, represents opinion only and is not intended to replace consultation with qualified healthcare providers. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
For legal purposes, please note that all information, opinions, and recommendations expressed in this newsletter are those of the individual authors and do not necessarily reflect the official policy or position of The Cancer Collectives or its affiliates.

The Cancer Collectives and its contributors disclaim any liability for any loss or damage incurred as a result of the use of information presented in this newsletter.

If you are experiencing a medical emergency, please contact your healthcare provider or call emergency services immediately.

Articles